Captrust Financial Advisors Increases Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Captrust Financial Advisors increased its position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 9.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,827 shares of the company’s stock after acquiring an additional 500 shares during the period. Captrust Financial Advisors owned approximately 0.12% of SPDR S&P Pharmaceuticals ETF worth $251,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. AlphaMark Advisors LLC raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 6.7% during the 4th quarter. AlphaMark Advisors LLC now owns 6,640 shares of the company’s stock worth $285,000 after buying an additional 415 shares during the last quarter. Jones Financial Companies Lllp raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 146.4% during the 4th quarter. Jones Financial Companies Lllp now owns 993 shares of the company’s stock worth $43,000 after buying an additional 590 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 36.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after buying an additional 1,182 shares during the last quarter. US Bancorp DE acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $96,000. Finally, Beacon Pointe Advisors LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $211,000.

SPDR S&P Pharmaceuticals ETF Stock Down 2.7%

NYSEARCA:XPH opened at $39.80 on Thursday. The company has a market capitalization of $137.31 million, a PE ratio of 14.61 and a beta of 0.61. SPDR S&P Pharmaceuticals ETF has a 52-week low of $35.22 and a 52-week high of $48.76. The stock has a fifty day simple moving average of $40.36 and a 200-day simple moving average of $43.22.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.